Earle Karen E, Seneviratne Tara, Shaker Joseph, Shoback Dolores
Endocrinology Division, Department of Medicine, University of California at San Francisco, San Francisco, California, USA.
J Bone Miner Res. 2004 May;19(5):714-21. doi: 10.1359/jbmr.2004.19.5.714.
We diagnosed Fanconi's syndrome (phosphate depletion and dysfunction of the renal tubules) in three HIV(+) patients. This was temporally related to their HIV treatment. Physicians caring for patients with HIV should recognize the association of this rare syndrome with antiretroviral medications and monitor their patients carefully.
Fanconi's syndrome is caused by increased excretion of phosphate, glucose, amino acids, and other intermediary metabolites, and can result in osteomalacia.
We diagnosed this syndrome in three HIV(+) patients.
The first was a 43-year-old woman referred for multiple painful stress fractures. She demonstrated hypophosphatemia, metabolic acidosis, phosphaturia, glucosuria, and generalized aminoaciduria. These abnormalities resolved with oral phosphate replacement and discontinuation of the antiretroviral medication tenofovir. The second patient was a 39-year-old man with hypophosphatemia and bone pain. His symptoms improved with discontinuation of adefovir and supplementation of phosphate, potassium, and calcitriol. The third patient was a 48-year-old man who presented with symptomatic tetany caused by hypocalcemia (total serum calcium of 6.5 mg/dl [8.5-10.5 mg/dl]). Nine months before presentation, he had been treated with cidofovir for retinitis caused by cytomegalovirus. With calcium, phosphate, potassium, and calcitriol therapy, his laboratory abnormalities improved substantially, although he continues to require daily electrolyte replacement.
Each patient demonstrated generalized renal tubular dysfunction temporally related to treatment with antiretroviral drugs. The mechanism responsible for these abnormalities is not known; however, physicians caring for patients with HIV disease should recognize the association of Fanconi's syndrome with antiretroviral medications and monitor susceptible patients to prevent potential skeletal and neuromuscular complications.
我们在3例HIV阳性患者中诊断出范科尼综合征(磷酸盐缺乏和肾小管功能障碍)。这在时间上与他们的HIV治疗相关。治疗HIV患者的医生应认识到这种罕见综合征与抗逆转录病毒药物的关联,并仔细监测他们的患者。
范科尼综合征是由磷酸盐、葡萄糖、氨基酸和其他中间代谢产物排泄增加引起的,可导致骨软化症。
我们在3例HIV阳性患者中诊断出该综合征。
首例患者为一名43岁女性,因多处疼痛性应力性骨折前来就诊。她表现为低磷血症、代谢性酸中毒、磷酸盐尿、糖尿和全身性氨基酸尿。通过口服补充磷酸盐和停用抗逆转录病毒药物替诺福韦,这些异常情况得到缓解。第二例患者是一名39岁男性,患有低磷血症和骨痛。停用阿德福韦并补充磷酸盐、钾和骨化三醇后,他的症状有所改善。第三例患者是一名48岁男性,因低钙血症(血清总钙为6.5mg/dl[8.5 - 10.5mg/dl])出现症状性手足搐搦。在就诊前9个月,他因巨细胞病毒引起的视网膜炎接受了西多福韦治疗。通过钙、磷酸盐、钾和骨化三醇治疗,他的实验室异常情况有了显著改善,尽管他仍需要每日补充电解质。
每位患者均表现出与抗逆转录病毒药物治疗在时间上相关的全身性肾小管功能障碍。导致这些异常的机制尚不清楚;然而,治疗HIV疾病患者的医生应认识到范科尼综合征与抗逆转录病毒药物的关联,并监测易感患者以预防潜在的骨骼和神经肌肉并发症。